BIVI FLEXcombo Swine Vaccine Available January 2015 in 50-Dose Presentation02 December 2014
US - Boehringer Ingelheim Vetmedica, Inc. (BIVI) makes it easier for producers and veterinarians to vaccinate pigs against porcine circovirus type 2 (PCV2) and Mycoplasma hyopneumoniae with a single injection of FLEXcombo®.
Now FLEXcombo, a member of the FLEX Family™ of vaccines, is now available in a new 50-dose presentation starting January 2015, in addition to a 250-dose presentation, giving producers and veterinarians a choice of sizes that best fit their operations and number of pigs to vaccinate, with less wasted vaccine.
According to Sarah Jorgensen, FLEX brand manager for the BIVI Swine Division, the packaging and mixing process for the new 50-dose FLEXcombo is the same as what producers are used to with the larger presentation size.
“The 50-dose FLEXcombo package contains a 50-mL bottle of Ingelvac CircoFLEX® and 50mL of Ingelvac MycoFLEX® in a 100-mL headspace bottle for easy mixing. The result is 100mL of mixed vaccine, enough to treat 50 head with a single 2-mL injection,” she explains.
Producers and veterinarians have asked for a smaller presentation of FLEXcombo so that they can better match vaccine quantity with the number of pigs they need to vaccine, while reducing the amount of left over vaccine.
“Customers now have more choice in product size to go along with the added convenience of vaccinating pigs against two of the most important respiratory diseases in swine, all with a single injection,” Ms Jorgensen adds.
“More importantly, customers using either presentation size of FLEXcombo can reduce stress on both pigs and people while decreasing labor costs because of the need for fewer injections. This all results in greater compliance with the Pork Quality Assurance Plus® programme and improved pork quality.”
For more information about FLEXcombo and other FLEX Family swine vaccines, contact your veterinarian, visit www.bi-vetmedica.com or call BIVI at 800-325-9167.
|ThePigSite News Desk||Read more Boehringer Ingelheim News here|